Condition 1: cardic arrhythmia. Condition 2: cardic arrhythmia. Condition 3: cardic arrhythmia. Condition 4: cardic arrhythmia. Condition 5: cardic arrhythmia. Ventricular tachycardia ??????????? ? ????? ?????? ??????????? ? ????? ???? ????? ????? ?????? ????? ????? ????
Conditions
Interventions
Intervention 1: 87 patients were given 3 g of magnesium sulphate (MgSO4) [20 ml = 24.32 mEq/L Mg+2] in 100 cc of isotonic 0.9% solution over 2 hours intravenously at the following times: 12 hours prio
Prevention
Placebo
87 patients were given 3 g of magnesium sulphate (MgSO4) [20 ml = 24.32 mEq/L Mg+2] in 100 cc of isotonic 0.9% solution over 2 hours intravenously at the following times: 12 hours prior to the operati
87patients were given 100 cc of isotonic 0.9% solution over 2 hours intravenously at the following times: 12 hours prior to the operation, immediately following the operation, and on postoperative day
Sponsors
Kermanshah University of Medical Sciences
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Inclusion criteria:l pateint candidate for coronary artery by-pass graft Exclusion criteria:renal and heart failure and history of arrythmia,used of anti arrythmic drug ,implantable cardiovertor deffibllirator
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Atrial fibrillation,atrial flutter.ventricular fibrillation,ventricular tackycardia,prematur ventricular complex,non sustained ventricular tackycardia. Timepoint: 24hour. Method of measurement: monitoring. | — |
Secondary
| Measure | Time frame |
|---|---|
| Cognitive status. Timepoint: daily. Method of measurement: Examination.;Coagebility status. Timepoint: daily. Method of measurement: lab.;Neurological status. Timepoint: daily. Method of measurement: examination. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMostafa Bahreman
Kermanshah University of Medical Sciences
Outcome results
None listed